Regeneron Pharmaceuticals REGN has outperformed the market over the past 10 years by 6.71% on an annualized basis producing an average annual return of 16.96%. Currently, Regeneron Pharmaceuticals has a market capitalization of $76.26 billion.
Buying $100 In REGN: If an investor had bought $100 of REGN stock 10 years ago, it would be worth $485.18 today based on a price of $699.56 for REGN at the time of writing.
Regeneron Pharmaceuticals's Performance Over Last 10 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.